A quick word on studies published in the Lancet and conducted by Professor Peter Rothwell (Oxford, UK), who threw a stone into the pond on management of hypertension.The researcher concluded that the variability of blood pressure of a medical consultation to another is itself a risk factor for stroke. By altering several extensive studies in hypertensive populations have already suffered a transient stroke, Peter Rothwell calculates that he risk of recurrence is more important than the systolic (first number tells you that ) varies from one consultation to another.Regardless of blood pressure level, the likelihood of a stroke is multiplied by 6 in 10% of subjects who had the highest blood pressure variability, compared to 10% with the lowest variability. Le risque d’infarctus est lui plus que triplé. The risk of stroke is it more than tripled.
Thus, episodic hypertension is also at risk and patients and their doctors should not be reassured by the fact that their blood pressure is sometimes normal. Professor Peter Rothwell goes further by showing that t ll drugs are not at par to stabilize the voltage. Drugs in the family of calcium channel blockers and diuretics are more effective than other classes of antihypertensive drugs such as beta blockers.These ads must reflect upon the impact the current strategies of management. Results and ads that do not shock over interpretation: connnait is now well in the white coat effect cabinet which modifies the blood pressure in the wrong direction. In addition, the socket must be made at rest, half sitting, without making prior exciting kind coffee or smoking … In other words mission impossible in general practice.
